chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Day 1 9hours after shot golf ball sized lump pain warm to touch Day 2  swelling in arm went to baseball size low grade fever chills headache body aches tired vomiting  Day 3 swelling in arm went to softball size vomiting headache muscle aches  tightness in chest
hot, red, hard at site of vaccine increasing in severity up until time of writing this body aches, fatigue, nausea, severe headache fever up to 101.8
Very Red Face,knuckles,neck,  itchy head, feet,hands, feelings of pins & needles, tingling, face felt like a mud mask had been applied& cracked---One week later still suffering symptoms
felt unwell; coughing; diarrhea; fever; chills; shutting pain under his pectoral muscle in left side; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt unwell), COUGH (coughing), DIARRHOEA (diarrhea), PYREXIA (fever) and CHILLS (chills) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced MALAISE (felt unwell), COUGH (coughing), DIARRHOEA (diarrhea), PYREXIA (fever), CHILLS (chills) and MYALGIA (shutting pain under his pectoral muscle in left side). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, MALAISE (felt unwell), COUGH (coughing), DIARRHOEA (diarrhea), PYREXIA (fever), CHILLS (chills) and MYALGIA (shutting pain under his pectoral muscle in left side) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.
Headache, body aches, fever, chills, tired Rest, ibuprofen, lots of water  Feeling better just some lingering body aches.
Erythema and swelling at injection site. Began 7 days after injection and has not resolved yet after two days. Grew larger in day 2
Sinus infection; 3 inches of red swelling around the injection site; 3 inches of red swelling around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Sinus infection), VACCINATION SITE SWELLING (3 inches of red swelling around the injection site) and VACCINATION SITE ERYTHEMA (3 inches of red swelling around the injection site) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Disability.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced SINUSITIS (Sinus infection), VACCINATION SITE SWELLING (3 inches of red swelling around the injection site) and VACCINATION SITE ERYTHEMA (3 inches of red swelling around the injection site). At the time of the report, SINUSITIS (Sinus infection), VACCINATION SITE SWELLING (3 inches of red swelling around the injection site) and VACCINATION SITE ERYTHEMA (3 inches of red swelling around the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.    No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow-up information received on 13 JUL 2021 contains change in the outcome. Outcome of the event Sinus infection, Vaccination site swelling and Vaccination site erythema has been updated from Not Recovered to Recovered .
Vaccine was administered. After vaccine form was reviewed. Patient seemed anxious, but received the vaccine without any issue. At the end of the 15 minute way period, patient was brought to counsel window stated that "itchy spots" appeared on patient wrist and arm. She was not experiencing any shortness of breath and spots were not spreading. Recommended patient take some Benadryl and patient said that this happens to her from time to time. Offered, but parent declined did not feel it was medically necessary to administer Benadryl as patient just had 2 spots on arm.
Information has been received from a physician and a licensed practical nurse concerning an approximately 20 year old "college age" female with seizure disorder and no known allergies who was vaccinated with all three doses of GARDASIL on 07-AUG-2007, 02-NOV-2007, and 24-JUL-2008 (1st lot # 657622/0388U, 2nd lot #658563/1063U, 3rd lot #660555/0279X), respectively. On 10-MAY-2010, after hearing reports in the media, the patient contacted her physician's office to report that she had more seizures. She had four seizures since her last dose of GARDASIL (no dates given for seizures). The patient was being seen by a neurologist. At the time of the report, the outcome was unknown. The health care professional contacted during telephone follow-up could not supply the following information: date of event, recovery status. Upon internal review, more seizures was considered to be an other important medical event. Additional information has been requested.
Shortness of breath, wheezing, tightness in throat, rash and hives
Round swollen red spot underneath injection site. Warm to the touch and painful to patient. Woke up this morning with reaction.
Cramps; vomiting; don't feel well; This is a spontaneous report from a contactable consumer (patient) via Medical information team. A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on 20Apr2021 on Tuesday at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the first dose and afterwards has experienced cramps, vomiting and not feeling well in Apr2021. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
On 10/27/2020 left side of face from below the cheekbone to brow felt like a sunburn and pins and needle sensation. Left ankle had intermittent bee sting ,burning, sharp sensation. On 10/28/2020 left temple and eye area sensitive to touch. No problem with the left ankle.
This patient received a dose of Janssen on 3/11/21 and then received a dose of Moderna on 5/13/21.
Pt stated she had a giant hive from shoulder to her elbow. Swollen and itchy. Still itches 1 week later.
48 hours duration. Fever 101.4 F, chills, aches and muscle pain, vomiting, and severe headache
The patient received dose two of Twinrix late; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 73-year-old male patient who received HAB (Twinrix) for prophylaxis.   Concomitant products included HEPATITIS A VACCINE + HEPATITIS B VACCINE (TWINRIX).   On 19-MAY-2023, the patient received the 2nd dose of Twinrix. On 19-MAY-2023, an unknown time after receiving Twinrix, the patient experienced drug dose administration interval too long (Verbatim: The patient received dose two of Twinrix late). The outcome of the drug dose administration interval too long was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 19-May-2023 The reporter consented to follow up. The reporter did not provide lot number and expiration date for dose two. The patient received 2nd dose of Twinrix, later than the recommended interval, which led to lengthening of vaccination schedule.
Gave patient MENACTRA (MCV4) vaccine instead of MENOMUNE (MPSV4).
Information has been received from a medical assistant concerning an 18 year old female with no pertinent medical history and no drug allergies, who "2 years ago", was vaccinated with the first dose of GARDASIL (0.5ml, IM). On 23-FEB-2010 the patient received the second dose (0.5ml, IM, lot # 662765/1353Y). There was no concomitant medication. The patient experienced the onset of dizziness 5 minutes after receiving her second dose on 23-FEB-2010. Paramedics were called to the office and the patient was evaluated. The patient was found to be stable and was released to home with her mother. There were no labs or diagnostic tests performed. The patient had declined to continue the vaccine series. The patient went in office for medical attention. The dizziness resolved by that evening of 23-FEB-2010 without requiring treatment. Follow up information has been received from a medical assistant concerning an 18 year old female who on 23-FEB-2010 at 4:00 PM received the second dose of GARDASIL (IM, lot # 662765/1353Y) in the left deltoid. On 23-FEB-2010 at 4:05 PM the patient experienced dizziness and nausea for approximately 6 to 10 hours following injection. The patient required doctor room visit and recovered on 24-FEB-2010. Additional information is not expected.
Developed an autoimmune vasculitis, then a temporal arteritis. Currently being treated with corticosteroids.  Diagnosed and treated by private MD.
4 days later tingling, numbness in arms, feet, hands legs-traveled to face all night. During day tingling, numbness different parts of the body ever changing. 1 to + spots under skin, shoulder, arms. Heavy footed tired calves both sides.
sore arm; fatigue; myalgia; neck pain; This case was reported by a physician via sales rep and described the occurrence of pain in arm in a male patient who received Men B NVS (Bexsero) for prophylaxis.   On an unknown date, the patient received Bexsero at an unknown dose. On an unknown date, unknown after receiving Bexsero, the patient experienced pain in arm, fatigue, myalgia and neck pain. On an unknown date, the outcome of the pain in arm, fatigue, myalgia and neck pain were unknown.   It was unknown if the reporter considered the pain in arm, fatigue, myalgia and neck pain to be related to Bexsero.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that the patient experienced side effects (sore arm, fatigue, myalgia, neck pain) following administration of Bexsero. The reporter was agree to follow up from GlaxoSmithKline.
TAKEN FROM THIS EARTH; HEART DISORDER; This spontaneous report received from a consumer via a company representative via media concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported, expiry date: unknown) dose, therapy start date were not reported, 1 total administered for prophylactic vaccination. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced heart disorder and was taken from this earth (death). The cause of death was unknown. As per reporter, "two dear friends trusted the J and J vaccine and were taken from this earth. One, blood clot. The other, heart. Way before their time." It was unknown if the autopsy was performed. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died on an unspecified date, and the outcome of heart disorder was not reported. This report was serious (Death). This case, from the same reporter is linked to 20220313454.; Sender's Comments: V0:20220313855-Covid-19 vaccine ad26.cov2.s-Taken from this earth.The event(s) has an unkown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered unassessable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Uncontrollable tremors, flopping around like a fish out of water, head pressure, like my head was a balloon and it was being inflated. Temporary paralysis, felt like a magnet was pulling me down. dizziness, light sensitivity, no appetite, blurred vision.   It really sucked......
Nerve pain in left arm. Especially in the elbow area and down the inside of arm. Very painful in the morning. Loss of strength in arm. Does not seem to be getting any better. Nurse said may be nerve damage.
Spikevax:.  headache, sore muscles, teeth hurt, skin hurts, hair hurts, no energy, tired,
Day 1-4 post vaccine: low grade fever up to 100.7, significant fatigue, soreness at site of injection. On Day 5 I was much better. On day 8 I woke up with a large red, swollen and itchy rash on left arm. On day 11. I still have the rash but it is not as itchy or swollen but still large and red. Approximately 6 inches x 4 inches.
I have chronic Lyme disease, with extreme symptoms of photosensitivity and photophobia.  12 years ago, I had a series of intravenous antibiotics for 9 months.  That halted the progression of the symptoms.  However, with the first injection of the Pfizer vaccine, I had an immediate and increasing photosensitivity/photophobia.  For example, my computer monitor was at 6% brightness.  I reset to 3% brightness, which is still too bright.  My concern is that the second injection due on February 12th may further increase the symptoms.  My Lyme doctor believes that the light sensitivity is perhaps coming from the thalamus.  Additionally, the injection seemed to increase my INR.
This spontaneous report was received from an office manager and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 12-MAY-2017,  the patient was inadvertently vaccinated with an expired dose of M-M-R II lot # K021950, expiration date 10-NOV-2016 (dose and route of administration were not reported) for prophylaxis. The M-M-R II  was reconstituted with a sterile diluent (STERILE DILUENT), lot# reported as K021920, expiration date 15-SEP-2017. No adverse effects were reported. No product quality complaint (PQC) was involved. Additional information has been requested.
A report has been received from a Pharmacist concerning a 7 year old, Female subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT started on 14-Dec-2013. The patient was inadvertently administered expired FLUMIST QUADRIVALENT on 14-Dec-2013. The outcome of the event of expired FLUMIST QUADRIVALENT administered is unknown. The report was considered to be non-serious.
impact from jumping and kicking many veins in lower legs are apparently weakened.; Incurred manyhematomas. These were not fromdirect contact to bruised area, thesewere in the veins surrounding; This is a spontaneous report from a contactable consumer. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 24Feb2021(at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history details are not available and patient did not had a history of allergies to food, medications, or other products. The patient received unspecified vitamin supplements within two weeks of vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 04Feb2021 at 16:00 (at the age of 44-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24Mar2021, in late March the patient experienced upon impact from jumping and kicking many veins in lower legs are apparently weakened and incurred many hematomas. These were not from direct contact to bruised area, these were in the veins surrounding, and above impact. This was not a typical ailment for patient and experienced same in early April. No therapeutic measures were taken as a result of events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event impact from jumping and kicking many veins in lower legs are apparently weakened and incurred many hematomas in the veins surrounding were recovering at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Information was received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 14-JUN-2016, the patient was vaccinated with an improperly stored dose of VARIVAX lot # L041207 (dose, route and expiration date not reported). Concomitant therapy was not reported. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a company representative concerning a 15 month old male who on 26-JAN-2008 was vaccinated with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). On 02-FEB-2008, the patient developed a fever and vomiting which lasted for 24 hours. On 04-FEB-2008, the patient developed a rash. It was noted that on 06 FEB 2008, the rash was almost gone. No further information is available.
she has been freezing since receiving her second COVID-19 Vaccine dose; She said the last 2 days she has been very nauseous. She said she was nauseous all day Thursday, 04Feb2021; Chills; Shaking; She clarified she is always cold, but her coldness seems to be worse at night.; This is a spontaneous report from a contactable consumer. A 82-Year-old female consumer receive second dose of COVID-19 Vaccine BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE,lot no: EL9262, formulation; solution for injection), via an unspecified route of administration on 03Feb2021, 10:30AM  as single dose at arm left for covid-19 immunisation. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot no: EL1284) on Jan2021 for covid-19 immunisation. The patients' Medical history included Partial knee replacement on 16Nov2020, ongoing Diabetes and Spinal stenosis. The patients concomitant medication was not reported.On 03 Feb 2021, the patient had been freezing since receiving her second COVID-19 Vaccine dose, she was nauseous all day , had chills and was shaking.  The patient took Extra Strength Tylenol 500mg. the outcome of event shaking was not recovered, chills and nausea was recovered on 03 Feb 2021.
The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify. Follow-up information has been received from the practice manager on 18-SEP-2018. This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided. On 03-AUG-2018, the patient was vaccinated with an improperly stored dose of RECOMBIVAX HB (Thimerosal free) (lot# R006746 and expiration date 19-NOV-2020) intramuscularly for prophylaxis (product storage error). The Merck Sterile Diluent (lot# and expiration date were unknown) was properly stored. No adverse event was reported. The excursion temperature on 08-NOV-2017, 16-NOV-2017, 23-JAN-2018, 06-JUN-2018, 03-JUL-2018 and 14-AUG-2018 was 47 degree Celsius for maximize 15 hours. The excursion temperature on 07-DEC-2017 was 50 degree Celsius for maximize 8.75 hours. The call was not because of data logger. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1810USA001951; US-009507513-1810USA001952; US-009507513-1810USA001953; US-009507513-1810USA001954; US-009507513-1810USA001955; US-009507513-1810USA001956; US-009507513-1810USA001957; US-009507513-1810USA001958; US-009507513-1810USA001959.
Swelling of arm, dizziness, vomiting, fever, chills, hot/tender arm.
Immediately had flu symptoms the same night as vaccine that went away within 2 days. HOWEVER,  twenty-one (21) days later, both eyes were extremely painful to move. Then I lost vision in right eye with extreme blurriness & partial blind spots resulting in a diagnosis of Optic Neuritis by Ophthalmologist and Neurologist. Confirmed optic Neuritis on MRI scan.  Twenty-four (24) days later, numbness in legs, feet and right arm started. Hard to walk up and down stairs. Twenty-six (26) days later, extreme pain in in muscles and skin along with tingles all over and numbness. Weakness and Chest pain. Flu like symptoms without fever ie: aches, pains, skin pain, confusion. Dizziness, feeling of being extremely anxious and out of sorts in space. Had to complete round of Steroids and numbness and tingles got better, but did not dissolve. After completion of IV steroids, thirty-four (34) days later all symptoms returned full force and worsening. Checked into ER 4/10 and admitted into hospital. Have not been able to complete normal routine or work level since March 27th due to neurological disturbance and symptoms.   Two (2) Eye exams, 3/30/21 confirming swollen optic nerves.  MRI 3/31/21 Blood work 4/2/21 CoVid Test 4/9/21 Negative  Hospital: April 10-12th.  MRI Extensive Blood work Spinal Tap Neuro-Opt exam  Outcome pending and further treatment pending results.
Sore arm; Difficulty walking; Low back pain; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), GAIT DISTURBANCE (Difficulty walking), BACK PAIN (Low back pain) and FATIGUE (Fatigue) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), GAIT DISTURBANCE (Difficulty walking), BACK PAIN (Low back pain) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) for Symptomatic treatment, at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (Sore arm), GAIT DISTURBANCE (Difficulty walking), BACK PAIN (Low back pain) and FATIGUE (Fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products were not provided by the reporter.     Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow-up information  contains no new information.
This spontaneous report as received from a pharmacy technician refers to a 67 year old female patient. No information regarding the patient's medical history or concurrent conditions was provided. The patient was not pregnant. On 11-APR-2016, the patient was vaccinated with a dose of PNEUMOVAX 23 injection (lot# M000386; dose, route of administration and expiry date were not reported). There were no concomitant therapies reported. On 11-APR-2016, also reported as "soon", the patient experienced rash, swollen and sore arm at the injection site. The patient did not seek medical attention. No treatment was given for the event. It was stated that therapy with PNEUMOVAX 23 was not discontinued and not reintroduced. The outcome of the events was not reported. The relatedness between PNEUMOVAX 23 and the events was not provided. This one of two reports received from the same reporter. Additional information has been requested.